Julie Tutkovics - Huntington Bancshares Senior Officer
| HBANL Stock | USD 26.14 0.03 0.11% |
Executive
Julie Tutkovics is Senior Officer of Huntington Bancshares Incorporated
| Age | 53 |
| Address | Huntington Center, Columbus, OH, United States, 43287 |
| Phone | 614 480 2265 |
| Web | https://www.huntington.com |
Julie Tutkovics Latest Insider Activity
Tracking and analyzing the buying and selling activities of Julie Tutkovics against Huntington Bancshares stock is an integral part of due diligence when investing in Huntington Bancshares. Julie Tutkovics insider activity provides valuable insight into whether Huntington Bancshares is net buyers or sellers over its current business cycle. Note, Huntington Bancshares insiders must abide by specific rules, including filing SEC forms every time they buy or sell Huntington Bancshares'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Julie Tutkovics over a year ago Acquisition by Julie Tutkovics of 29411 shares of Huntington Bancshares subject to Rule 16b-3 |
Huntington Bancshares Management Efficiency
At this time, Huntington Bancshares' Return On Capital Employed is quite stable compared to the past year. Return On Equity is expected to rise to 0.11 this year, although the value of Return On Tangible Assets will most likely fall to 0.01. At this time, Huntington Bancshares' Total Assets are quite stable compared to the past year. Non Current Assets Total is expected to rise to about 11.9 B this year, although the value of Total Current Assets will most likely fall to about 9.9 B. Huntington Bancshares' management efficiency ratios could be used to measure how well Huntington Bancshares manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Kimberly Maready | Old Dominion Freight | 53 | |
| MBA MD | Aquestive Therapeutics | 66 | |
| Erin Gull | Cumberland Pharmaceuticals | N/A | |
| Cassie Jung | Aquestive Therapeutics | 45 | |
| Arvind Sood | Amgen Inc | N/A | |
| Matthew Busch | Amgen Inc | 50 | |
| Justin Claeys | Amgen Inc | N/A | |
| JoAnne Alkire | Merit Medical Systems | N/A | |
| Carl MD | Aquestive Therapeutics | 54 | |
| Kave Niksefat | Amgen Inc | N/A | |
| Colton Snow | Sun Country Airlines | N/A | |
| Nancy Grygiel | Amgen Inc | 56 | |
| Todd Anthony | Cumberland Pharmaceuticals | 63 | |
| Sherry Korczynski | Aquestive Therapeutics | N/A | |
| Alan Russell | Amgen Inc | N/A | |
| Sam Faucette | Old Dominion Freight | N/A | |
| Steven Hartsell | Old Dominion Freight | 56 | |
| Michael Karicher | Sonida Senior Living | 54 | |
| James MD | Amgen Inc | 52 | |
| John Hamm | Cumberland Pharmaceuticals | 68 | |
| Kenneth Marshall | Aquestive Therapeutics | 65 | |
Management Performance
| Return On Equity | 0.0855 | ||||
| Return On Asset | 0.0087 |
Huntington Bancshares Leadership Team
Elected by the shareholders, the Huntington Bancshares' board of directors comprises two types of representatives: Huntington Bancshares inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Huntington. The board's role is to monitor Huntington Bancshares' management team and ensure that shareholders' interests are well served. Huntington Bancshares' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Huntington Bancshares' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Susan Shipley, Ohio Pennsylvania | ||
| Kendall Kowalski, Executive Officer | ||
| Timothy Miller, Executive Officer | ||
| Zachary Wasserman, CFO EVP | ||
| Julie Tutkovics, Senior Officer | ||
| Marcy Hingst, General Counsel | ||
| Sharon Speyer, President Region | ||
| Prashant Nateri, Chief Officer | ||
| Helga Houston, Senior Officer | ||
| Stephen Steinour, President Chairman | ||
| Rajeev Syal, Senior President | ||
| Scott Kleinman, Senior Banking | ||
| Barbara Benham, Chief VP | ||
| Nancy Maloney, Controller VP | ||
| Sarah Pohmer, Senior Officer | ||
| Brantley Standridge, Senior Banking | ||
| Paul Heller, Chief EVP | ||
| Sean Richardson, President Region | ||
| Timothy Sedabres, Executive Relations | ||
| Sue Zazon, President Region |
Huntington Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Huntington Bancshares a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0855 | ||||
| Return On Asset | 0.0087 | ||||
| Profit Margin | 0.25 % | ||||
| Operating Margin | 0.38 % | ||||
| Current Valuation | 43.58 B | ||||
| Shares Owned By Institutions | 37.72 % | ||||
| Number Of Shares Shorted | 47.01 K | ||||
| Revenue | 7.36 B | ||||
| Gross Profit | 6.96 B | ||||
| EBITDA | 3.18 B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Huntington Bancshares Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Regional Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Huntington Bancshares. If investors know Huntington will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Huntington Bancshares listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Dividend Share 0.62 | Revenue Per Share 4.613 | Quarterly Revenue Growth (0.01) | Return On Assets 0.0087 |
The market value of Huntington Bancshares is measured differently than its book value, which is the value of Huntington that is recorded on the company's balance sheet. Investors also form their own opinion of Huntington Bancshares' value that differs from its market value or its book value, called intrinsic value, which is Huntington Bancshares' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Huntington Bancshares' market value can be influenced by many factors that don't directly affect Huntington Bancshares' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Huntington Bancshares' value and its price as these two are different measures arrived at by different means. Investors typically determine if Huntington Bancshares is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Huntington Bancshares' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.